← SynDRA
BUMETANIDE
SynDRA canonical compound SYN0003511 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SLC12A2 |
|---|
| Mechanism of action | Solute carrier family member inhibitor |
|---|
| Indication | congestive heart failure | edema |
|---|
| Disease area | cardiology |
|---|
All known targets
- SLC12A1
- SLC12A2
- GPR35
- ATP1A1
- CFTR
- SLC12A4
- SLC12A5
Mechanisms of action (all sources)
- Solute carrier family member inhibitor
- SLC12A1 INHIBITOR
- Sodium-(potassium)-chloride cotransporter 2 inhibitor
- SLC12A2 INHIBITOR
- GPR35 AGONIST
- SLC12A1 BLOCKER
Drug classes
- Loop Diuretic
- Diuretics
- Membrane Transport Modulators
- Natriuretic Agents
- Sodium Potassium Chloride Symporter Inhibitors
ATC classes
- C03C · HIGH-CEILING DIURETICS
- DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION
Cross-references
Synonyms
- bumethanide
- bufenox
- Bumetanida
- PF-1593
- PF1593
- RO-10-6338
- RO-106338
- RO10-6338
- S-95008.
- S95008.
- Betinex
- Bumex
- Burinex
- Lixil
- Aquazone
- Bumedyl
- Bumetanidum
- Bumethanide
- Burine
- Butinat
- Cambiex
- Diurama
- Drenural
- Fontego
- Fordiuran
- Lunetoron
- Miccil
- Segurex
- Yurinex
- AstraZeneca Brand of Bumetanide
- Atlantis Brand of Bumetanide
- Bumetanide AstraZeneca Brand
- Bumetanide Atlantis Brand
- Bumetanide Farmacusi Brand
- Bumetanide Grossmann Brand
- Bumetanide Leo Brand
- Bumetanide Roche Brand
- Bumetanide Senosiain Brand
Reported adverse events
Look up BUMETANIDE in the interactive SynDRA portal →